100 results on '"Wedzicha, Jadwiga A"'
Search Results
2. Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals
3. Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease
4. Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement
5. Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
6. Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories
7. Airway Mucins in Chronic Obstructive Pulmonary Disease
8. Randomized Double-Blind Controlled Trial of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease
9. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
10. Prediction of Chronic Obstructive Pulmonary Disease Exacerbation Frequency. Clinical Parameters Are Still Better Than Biomarkers
11. Hospitalized Exacerbations of COPD: Risk Factors and Outcomes in the ECLIPSE Cohort
12. Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?
13. AJRCCM 2017: 100-Year Anniversary
14. Eosinophils as Biomarkers of Chronic Obstructive Pulmonary Disease Exacerbation Risk. Maybe Just for Some?
15. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development
16. Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
17. Update in Chronic Obstructive Pulmonary Disease 2014
18. Mechanisms of Chronic Obstructive Pulmonary Disease Exacerbations
19. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease
20. Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial
21. Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease
22. Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
23. Upper Respiratory Symptoms Worsen over Time and Relate to Clinical Phenotype in Chronic Obstructive Pulmonary Disease
24. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
25. Editorial Changes and Opportunities at the AJRCCM
26. Community-based recruitment of patients with COPD into clinical research
27. Sputum-to-serum hydrogen sulfide ratio in COPD
28. The CODEX Index: A Collection or Digest of Laws: A Code
29. Rapid FEV1 Decline, Early COPD, and Angiotensin-Converting Enzymes?
30. Should medical journals publish sponsored content?
31. Evidence Roflumilast Reduces Severe Exacerbations?
32. Minimal Clinically Important Differences in Pharmacological Trials
33. Glycopyrronium and Tiotropium Demonstrate Similar Improvements in Lung Function and Reductions in Exacerbations in Severe-To-Very Severe COPD: The SPARK Study: OS215
34. Cardiovascular Risk, Myocardial Injury, and Exacerbations of Chronic Obstructive Pulmonary Disease
35. Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype
36. Chronic Cough in Chronic Obstructive Pulmonary Disease: Time for Listening?
37. Stakeholder Involvement: How to Do It Right: Article 9 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
38. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD
39. Natural history of successive COPD exacerbations
40. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations
41. The Impact of Ischemic Heart Disease on Symptoms, Health Status, and Exacerbations in Patients With COPD
42. Time course and pattern of COPD exacerbation onset
43. Influence of Season on Exacerbation Characteristics in Patients With COPD
44. Reduced Lung-Cancer Mortality with CT Screening
45. Intersession repeatability of a novel nasal lavage technique
46. Outdoor air pollution and respiratory health in patients with COPD
47. Choice of Bronchodilator Therapy for Patients with COPD
48. Reported Pneumonia in Patients With COPD: Findings From the INSPIRE Study
49. Susceptibility to Exacerbation in COPD
50. BODE plus DOSE plus equals DO RE MI BOX?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.